Plant Health Care - Director / PDMR Shareholding
14/10/2022 10:39
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221014:nRSN9502Ca&default-theme=true
RNS Number : 9502C Plant Health Care PLC 14 October 2022
Plant Health Care plc
("Plant Health Care" or "the Company")
Director / PDMR Shareholding
and Total Voting Rights
Plant Health Care, a leading provider of novel patent-protected biological
products to global agricultural markets, announces that, on 12 October 2022, a
total of 2,275,000 new Ordinary Shares (the 'New Ordinary Shares') were issued
pursuant to the exercise of options by employees under the Company's 2017
Employee Share Option Plan (the 'Plan').
As announced on 7 October 2020, the Company had awarded 6,500,000 Options (the
'Options') to employees with an exercise price of 1p per ordinary share in the
Company (the 'Ordinary Shares'). Under the Plan the Options vest upon the
earlier of: (a) the date of a Change of Control; or (b) upon satisfaction of
the Performance-Based Requirement. The Performance-Based Requirement in
respect of 70% of the Options (rounded to the nearest whole number) is that no
Option may be exercised until the date on which the arithmetic mean closing
price of the Ordinary Shares over 30 consecutive trading dates after the date
of grant has exceeded 15p per Share. This criteria was achieved and, as a
result, certain employees have decided to exercise their Options.
Of the Options exercised, Jeffrey Tweedy, Chief Executive Officer, and Jeffrey
Hovey, Chief Financial Officer, have each exercised 827,273 Options.
Following these transactions, Jeffrey Hovey is interested in 871,696 Ordinary
Shares representing 0.28% of the issued share capital of the Company and
Jeffrey Tweedy is interested in 956,426 Ordinary Shares representing 0.31% of
the issued share capital of the Company
Application for admission of the New Ordinary Shares to trading on AIM
('Admission') has been made and dealings in the New Ordinary Shares are
expected to commence on or around 8.00 a.m. on 20 October 2022. The New
Ordinary Shares will rank pari-passu with the Company's existing issued
Ordinary Shares.
Total voting rights
Following the issue of the New Ordinary Shares, the Company has 306,937,482
Ordinary Shares in issue with no shares held in treasury. This is the total
number of voting rights in the Company and may be used by shareholders as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or change to their interest in, the
Company under the Financial Conduct Authority's Disclosure Guidance and
Transparency Rules.
Enquiries
Plant Health Care plc +1 919 926 1600
Jeffrey Tweedy - Chief Executive Officer
Jeffrey Hovey - Chief Financial Officer
Cenkos Securities plc - Nomad and Broker +44 (0)131 220 9771
Neil McDonald / Peter Lynch
SEC Newgate - Financial Communications +44 (0) 7540 10666
Robin Tozer / Richard Bicknell / George Esmond phc@secnewgate.co.uk
Company website: www.planthealthcare.com (http://www.planthealthcare.com)
The information set out below is provided in accordance with the requirements
of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Jeffrey Tweedy
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Plant Health Care plc
b) LEI
213800KBQPJZ2FM8QH27
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 1p each
GB00B01JC540
Identification code
b) Nature of the transaction Issue of Shares following exercise of options
c) Price(s) and volume(s) Price(s) Volume(s)
£0.01 827,273
d) Aggregated information
- Aggregated volume
- Price 827,273
£8,272.73
e) Date of the transaction 12.10.2022
f) Place of the transaction AIM, London Stock Exchange
d)
Aggregated information
- Aggregated volume
- Price
827,273
£8,272.73
e)
Date of the transaction
12.10.2022
f)
Place of the transaction
AIM, London Stock Exchange
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Jeffrey Hovey
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Plant Health Care plc
b) LEI
213800KBQPJZ2FM8QH27
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 1p each
GB00B01JC540
Identification code
b) Nature of the transaction Issue of Shares following exercise of options
c) Price(s) and volume(s) Price(s) Volume(s)
£0.01 827,273
d) Aggregated information
- Aggregated volume
- Price 827,273
£8,272.73
e) Date of the transaction 12.10.2022
f) Place of the transaction AIM, London Stock Exchange
d)
Aggregated information
- Aggregated volume
- Price
827,273
£8,272.73
e)
Date of the transaction
12.10.2022
f)
Place of the transaction
AIM, London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHGCBDGSXBDGDS